Novo Nordisk’s Obesity Drug Activities Break UK Rules Again

Pharmacists’ Prescribing Of Saxenda Returns To Spotlight

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".